GHMAP public pages and workflows are not intended for patient data, medical records, diagnosis, treatment decisions, emergency use, or patient-specific clinical decisions. Market-access information should be independently verified before business use.
Disclaimer notice
Disclaimer
GHMAP provides market-access organization and review workflows. It does not provide medical, legal, regulatory, reimbursement, investment, or market-entry advice.
Disclaimer notice
The disclaimer in full
Each limitation is separately linkable, so legal review can cite a specific section rather than the whole page.
Clause 01
Market-access intelligence only
GHMAP provides healthcare market-access intelligence for business planning and professional review. It helps organize questions, source status, confidence context, and next actions; it does not make final business, clinical, legal, regulatory, reimbursement, or investment determinations.
Clause 02
No medical advice
GHMAP does not provide medical advice, clinical diagnosis, treatment advice, or recommendations for patient care.
Clause 03
No patient-specific use
GHMAP public pages and market-access workflows are not designed for patient-specific information, patient records, medical histories, or individual clinical decisions.
Clause 04
No clinical decision support
GHMAP is not clinical decision support and should not be used to diagnose, treat, monitor, or manage any patient or condition.
Clause 05
No legal advice
GHMAP does not provide legal advice. Legal interpretations, contractual obligations, privacy obligations, compliance duties, and jurisdiction-specific legal questions require qualified counsel.
Clause 06
No regulatory approval guarantee
GHMAP does not guarantee regulatory approval, registration, clearance, certification, authorization, acceptance, or pathway eligibility in any jurisdiction.
Clause 07
No reimbursement guarantee
GHMAP does not guarantee reimbursement, payer coverage, coding, pricing, procurement, formulary placement, payment rates, or health technology assessment outcomes.
Clause 08
No investment advice
GHMAP does not provide investment advice, valuation advice, securities recommendations, transaction recommendations, or guarantees of commercial return.
Clause 09
Source freshness and verification
Regulatory, reimbursement, payer, and market-access sources can change. Source dates, review dates, jurisdiction tags, and confidence levels should be checked before business use.
Clause 10
Sample brief limitations
Sample briefs and demo previews are for product illustration only. They may use labels such as Source required, To be verified, Example only, or Professional review needed and should not be treated as conclusions.
Clause 11
Professional review required
Market-access content requires qualified professional review before business use, including regulatory, reimbursement, legal, compliance, clinical, commercial, and local-market review where appropriate.
Clause 12
External source limitations
External source materials may be incomplete, outdated, unavailable, interpreted differently by local experts, or subject to access restrictions. GHMAP users must verify external sources independently.
Clause 13
No emergency use
GHMAP is not for emergencies, urgent clinical decisions, medical triage, or any patient-care situation. Seek appropriate emergency or professional medical services when needed.
Professional review is required before business use. Questions about this notice can be sent to support@ghmap.io.